The application of sentinel lymph node mapping in colon cancer
The application of sentinel lymph node mapping in colon cancer
复制标题
DOI：
10.1016/j.suronc.2007.10.024
复制
发表时间：
2007-12-01
影响因子：
2.3
通讯作者：
Dionigi, R.
中科院分区：
文献类型：
--
作者：
Dionigi, G.;Castano, P.;Dionigi, R.
淋巴结状况是影响结直肠癌预后的最重要因素。完整的淋巴清扫历来是这些疾病外科治疗中不可或缺的一部分。前哨淋巴结标测是一项较新的技术，它允许选择性地切除第一个引流肿瘤的结节。前哨淋巴结标测被广泛接受用于乳腺癌和皮肤黑色素瘤的治疗，并在不影响存活率的情况下降低了发病率。前哨节点标测目前正在研究用于结直肠癌的治疗。最近的研究表明，将前哨节点标测技术结合起来用于治疗几种胃肠道恶性肿瘤是有希望的。(C)2007爱思唯尔有限公司。保留所有权利。
Lymph node status is the most important prognostic factor for colorectal carcinoma. Complete lymph node dissection has historically been an integral part of the surgical treatment of these diseases. Sentinel lymph node mapping is a newer technology that allows selective removal of the first node draining a tumor. Sentinel node mapping is well accepted for the management of breast carcinoma and cutaneous melanoma, and has resulted in reduced morbidity without adversely affecting survival. Sentinel node mapping is currently being investigated for treatment of colorectal cancers. Recent studies show promise for incorporating the sentinel node mapping technique for treatment of several gastrointestinal malignancies. (c) 2007 Elsevier Ltd. All rights reserved.